Free Trial

AbbVie (ABBV) Insider Trading & Ownership

AbbVie logo
$207.31 -3.29 (-1.56%)
As of 03:44 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

AbbVie (NYSE:ABBV) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.25%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$34.78M
Get ABBV Insider Trade Alerts

Want to know when executives and insiders are buying or selling AbbVie stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ABBV Insider Buying and Selling by Quarter

AbbVie Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/12/2025Azita Saleki-GerhardtEVPSell42,370$198.42$8,407,055.40  
8/5/2025Nicholas DonoghoeEVPSell13,295$198.51$2,639,190.45  
8/4/2025Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$197.05$1,001 - $15,000
7/22/2025Lisa C. McClainU.S. Congress Member (R-MI)Buy$187.10$1,001 - $15,000
7/22/2025Lisa C. McClainU.S. Congress Member (R-MI)Sell$187.10$1,001 - $15,000
7/11/2025Ritchie TorresU.S. Congress Member (D-NY)Sell$192.32$1,001 - $15,000
7/1/2025Ro KhannaU.S. Congress Member (D-CA)Buy$189.92$1,001 - $15,000
6/17/2025Lisa C. McClainU.S. Congress Member (R-MI)Buy$185.41$1,001 - $15,000
5/28/2025Ro KhannaU.S. Congress Member (D-CA)Buy$182.98$15,001 - $50,000
5/22/2025Josh GottheimerU.S. Congress Member (D-NJ)Buy$182.32$1,001 - $15,000
5/15/2025Robert Bresnahan, Jr.U.S. Congress Member (R-PA)Buy$181.52$1,001 - $15,000
5/5/2025Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$196.04$1,001 - $15,000
4/17/2025Josh GottheimerU.S. Congress Member (D-NJ)Sell$172.78$1,001 - $15,000
4/17/2025Jefferson ShreveU.S. Congress Member (R-IN)Sell$172.78$50,001 - $100,000
4/8/2025Robert Bresnahan, Jr.U.S. Congress Member (R-PA)Sell$175.03$1,001 - $15,000
4/7/2025Jared MoskowitzU.S. Congress Member (D-FL)Buy$186.11$1,001 - $15,000
4/3/2025Josh GottheimerU.S. Congress Member (D-NJ)Buy$201.31$1,001 - $15,000
4/3/2025Dwight EvansU.S. Congress Member (D-PA)Sell$201.31$1,001 - $15,000
4/1/2025Josh GottheimerU.S. Congress Member (D-NJ)Buy$206.08$1,001 - $15,000
3/31/2025Jeffrey Ryan StewartEVPSell58,832$210.08$12,359,426.56  
3/17/2025Marjorie Taylor GreeneU.S. Congress Member (R-GA)Buy$214.45$1,001 - $15,000
2/26/2025Kevin K BuckbeeSVPSell18,944$203.41$3,853,399.04  
2/26/2025Timothy J RichmondEVPSell29,917$202.90$6,070,159.30  
2/25/2025Robert Bresnahan, Jr.U.S. Congress Member (R-PA)Buy$204.19$1,001 - $15,000
2/24/2025Jefferson ShreveU.S. Congress Member (R-IN)Buy$204.02$50,001 - $100,000
2/20/2025Perry C SiatisEVPSell5,778$197.90$1,143,466.20  
1/15/2025Jared MoskowitzU.S. Congress Member (D-FL)Buy$171.32$1,001 - $15,000
12/16/2024Kevin K BuckbeeSVPSell1,800$172.24$310,032.00  
(Data available from 1/1/2013 forward)

ABBV Insider Trading Activity - Frequently Asked Questions

0.25% of AbbVie stock is owned by insiders. Learn more on ABBV's insider holdings.

The following insiders have sold ABBV shares in the last 24 months: Azita Saleki-Gerhardt ($17,591,103.10), Jeffrey Ryan Stewart ($22,898,918.27), Kevin K Buckbee ($5,072,118.64), Nicholas Donoghoe ($6,806,491.69), Perry C Siatis ($5,339,325.72), Richard A Gonzalez ($86,473,913.32), Robert A Michael ($12,153,699.55), Scott T Reents ($2,509,001.60), and Timothy J Richmond ($6,070,159.30).

Insiders have sold a total of 906,517 AbbVie shares in the last 24 months for a total of $164,914,731.19 sold.

Marjorie Taylor Greene (R-GA), Lisa C. McClain (R-MI), Ro Khanna (D-CA), Josh Gottheimer (D-NJ), Robert Bresnahan, Jr. (R-PA), Jared Moskowitz (D-FL), Jefferson Shreve (R-IN), and Virginia Foxx (R-NC) have bought shares of AbbVie in the last year totaling $227,500. Lisa C. McClain (R-MI), Ritchie Torres (D-NY), Josh Gottheimer (D-NJ), Jefferson Shreve (R-IN), Robert Bresnahan, Jr. (R-PA), Dwight Evans (D-PA), and John James (R-MI) have sold shares totaling $123,000.

AbbVie Key Executives



This page (NYSE:ABBV) was last updated on 8/25/2025 by MarketBeat.com Staff
From Our Partners